Sign In

News Story

ASCO annual meeting has wrapped up

ACS had a key presence at global oncology conference.

June 3 marks the start of the American Society of Clinical Oncology Annual Meeting, held online and in person through June 7. With more than 40,000 oncology professionals from around the world attending, this meeting is one of the largest, most diverse in global oncology. For the American Cancer Society, it is an opportunity to drive awareness of our organization’s relevance and impact across the cancer care continuum.

The theme of the 2022 annual meeting is “Advancing Equitable Cancer Care Through Innovation,” and will focus on how by innovating across boundaries, we can bring down barriers to access and make care more equitable, convenient, and efficient for patients worldwide. Attendees include ASCO members, National Cancer Institute-designated cancer centers, cancer care clinicians, pharmaceutical company representatives, and advocacy groups.

ACS will have a strong presence at the event, with nearly a dozen staff and ACS-funded researchers presenting during the meeting. The organization will also host a reception for key partners as well as a booth in the exhibition hall to demonstrate how the organization is impacting the lives of people facing cancer.

A key goal of the organization’s presence at the meeting is to emphasize ACS is the only organization that integrates advocacy, discovery, and direct patient support, which measurably improves lives, and that as a global leader in the cancer fight, we know cancer affects everyone, but it doesn’t affect everyone equally. We are working to ensure everyone has a fair and just opportunity to prevent, detect, treat, and survive cancer.

ASCO is an important partner for ACS. In early 2022, the two organizations launched a collaboration involving content-sharing on ASCO’s and

ACS staff and ACS-funded researchers presenting at the conference: 

    • Robin Yabroff: Education Session, Cancer Groundshot: Addressing the Global and National Inequities in Cancer Care
    • Arif Kamal, MD, MBA, MHS: Presentation in the Patient Advocate Lounge
    • Hyuna Sung, PhD: Poster Session, Symptoms and Survivorship, Racial differences in cardiovascular disease mortality among cancer survivors
    • Xuesong Han, PhD: Poster Session, Symptoms and Survivorship, Suicide risk among patients with cancer in the United States, 2000-2016
    • Jason Zheng, PhD: Poster Discussion Session, Symptoms and Survivorship, Association of parental cancer and minor child’s unmet economic needs in food, housing, and transportation
    • Mark Fleury of ACS CAN: Education Session: Strategies to Advance Equity in Cancer Clinical Trials
    • Xuesong Han, PhD: Poster Session, Prevention, Risk Reduction, and Hereditary Cancer, Racial and ethnic disparities in lifestyle changes during the COVID-19 pandemic: Exploring the socioeconomic and psychosocial mechanisms
    • Leticia Noguiera, PhD: Poster Session, Health Services Research and Quality Improvement, Racial disparities in receipt of guideline-concordant care for early-onset colorectal cancer in the U.S.
    • Sylvia Kewei Shi, MPH: Poster Session, Oncologist consideration of patient health insurance coverage and out-of-pocket costs for genomic testing in treatment decision 
    • Jingxuan Zhao, MPH: Poster Session, Health Services Research and Quality Improvement
  • Changes in cancer-related mortality during the COVID-19 pandemic in the United States

    • Xuesong Han, PhD: Oral Abstract, Care Delivery and Regulatory Policy: Association between the Affordable Care Act Medicaid expansion and survival in young adults newly diagnosed with cancer

Be sure to follow along on social media to see the latest from ASCO during the next few days.

ACSon Twitter:

ASCO social channels: 

 For questions related to ACS participation at ASCO, please contact Kathleen Goss, vice president, regional cancer support.

back to top